Literature DB >> 24388634

Atrial fibrillation: a progressive atrial myopathy or a distinct disease?

Eleftherios M Kallergis1, Christos A Goudis2, Panos E Vardas2.   

Abstract

Atrial fibrillation is a complex arrhythmia with multiple possible mechanisms. A lot of experimental and clinical studies have shed light on the pathophysiological mechanisms of arrhythmia, especially on molecular basis. Electrical, contractile and structural remodeling, calcium handling abnormalities, autonomic imbalance and genetic factors seem to play a crucial role in atrial fibrillation initiation and maintenance. However, the exact pathophysiological mechanisms of atrial fibrillation are not completely understood and whether atrial fibrillation is an unclassified cardiomyopathy or a distinct disease still remains to be answered. This review highlights proarrhythmic and pathophysiological mechanisms of atrial fibrillation and approaches the molecular basis underlying atrial fibrillation susceptibility.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Atrial fibrosis; Cardiomyopathy; Myopathy; Remodeling

Mesh:

Year:  2013        PMID: 24388634     DOI: 10.1016/j.ijcard.2013.12.009

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Role of the PPAR pathway in atrial fibrillation associated with heart valve disease: transcriptomics and proteomics in human atrial tissue.

Authors:  Huan-Xin Chen; Ming-Yang Li; Yi-Yao Jiang; Hai-Tao Hou; Jun Wang; Xiao-Cheng Liu; Qin Yang; Guo-Wei He
Journal:  Signal Transduct Target Ther       Date:  2020-01-17

2.  Fibroblast growth factor-21 is positively associated with atrial fibrosis in atrial fibrillation patients with rheumatic heart disease.

Authors:  Rui Wang; Xin Yi; Xiaoyan Li; Xuejun Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  DECAAF: Emphasizing the importance of MRI in AF ablation.

Authors:  Mohamed ElMaghawry; Soha Romeih
Journal:  Glob Cardiol Sci Pract       Date:  2015-03-23

Review 4.  Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models.

Authors:  Lois Choy; Jie Ming Yeo; Vivian Tse; Shing Po Chan; Gary Tse
Journal:  Int J Cardiol Heart Vasc       Date:  2016-09

5.  Association between left atrial function assessed by speckle-tracking echocardiography and the presence of left atrial appendage thrombus in patients with atrial fibrillation.

Authors:  Karolina Kupczynska; Blazej W Michalski; Dawid Miskowiec; Jaroslaw D Kasprzak; Paulina Wejner-Mik; Katarzyna Wdowiak-Okrojek; Piotr Lipiec
Journal:  Anatol J Cardiol       Date:  2017-05-30       Impact factor: 1.596

6.  Inhibition of renin-angiotensin axis reduces the risk of thrombus formation in the left atrial appendage in patients with hypertension complicated by atrial fibrillation.

Authors:  Ya Suo; Zhiwei Zhang; Huaying Fu; Yue Zhang; Meng Yuan; Yuanyuan Wang; Christos A Goudis; Gary Tse; Tong Liu; Guangping Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Apr-Jun       Impact factor: 1.636

7.  Entropy Mapping Approach for Functional Reentry Detection in Atrial Fibrillation: An In-Silico Study.

Authors:  Juan P Ugarte; Catalina Tobón; Andrés Orozco-Duque
Journal:  Entropy (Basel)       Date:  2019-02-18       Impact factor: 2.524

8.  Implication of Apnea-Hypopnea Index, a Measure of Obstructive Sleep Apnea Severity, for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.

Authors:  Haobo Xu; Juan Wang; Jiansong Yuan; Fenghuan Hu; Weixian Yang; Chao Guo; Xiaoliang Luo; Rong Liu; Jingang Cui; Xiaojin Gao; Yushi Chun; Shubin Qiao
Journal:  J Am Heart Assoc       Date:  2020-04-16       Impact factor: 5.501

9.  Association of left atrial deformation indices with left atrial appendage thrombus in patients with non valvular atrial fibrillation.

Authors:  Shaimaa Mostafa; Khaled El-Rabbat; Safaa Salah; Eman Elkeishk
Journal:  Indian Heart J       Date:  2020-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.